Literature DB >> 29354508

Seminal vesicle schwannoma presenting as rectal pain: successful robotic-assisted excision.

Molly A Elmer-DeWitt1, Bradley C Gill1,2, Raman Unnikrishnan1,3, Andrew J Stephenson1,2.   

Abstract

Schwannomas, not uncommon in the head and neck, rarely occur in the pelvis. Here we describe a seminal vesicle schwannoma, the first of its kind successfully excised via robotic surgery. An otherwise well 62 year-old male presented with a complaint of rectal pain. Colonoscopy identified a mass effect on the rectum, suggesting an external lesion. A computed tomography scan revealed a right seminal vesicle mass. Transrectal ultrasound guided biopsy returned a tissue diagnosis of schwannoma. To aid in operative planning, magnetic resonance imaging of the prostate and pelvis was obtained with and without contrast. This defined a 5 × 4 × 4 cm3 mass abutting the right seminal vesicle without evidence of invasion into adjacent structures. The patient underwent an elective robotic-assisted laparoscopic resection of the mass. Final pathology demonstrated a completely excised schwannoma arising from the soft tissue adherent to the right seminal vesicle.

Entities:  

Keywords:  Schwannoma; pelvic mass; robotic surgery

Year:  2017        PMID: 29354508      PMCID: PMC5760379          DOI: 10.21037/tau.2017.10.03

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


Introduction

Schwannomas, also known as neurilemmomas, are benign peripheral nerve sheath tumors (1). They are most commonly located in the head and neck, or extremities, less commonly in the mediastinum, retroperitoneum, and very rarely in the pelvis (2,3). A number of familial syndromes are associated with increased risk for schwannoma, including Neurofibromatosis type II, Schwannomatosis, or Carney complex (1). Malignant transformation is incredibly rare (4).

Case presentation

A 62-year-old male presented to gastroenterology with a chief complaint of rectal pain. The pain was exacerbated by defecation and prolonged sitting, was described as sharp in nature, and reached a ten-of-ten severity when at its peak. The patient denied changes in bowel habits or urinary function. The patient’s medical history was otherwise limited to hypertension, controlled with atenolol, and degenerative disc disease requiring occasional tramadol use. Family history was negative for neoplasms aside from a brain tumor in his father at age 83. He is a nonsmoker and works as a manager at a communications firm. He was referred to urology clinic for concern of a seminal vesicle mass found on workup for his rectal pain. He was well appearing without detectable abnormalities on abdominal and external genitourinary exams. His rectal exam was significant for a palpable mass on the right superior aspect of the prostate. Urinalysis and complete blood count were unremarkable and the prostate-specific antigen was 3.24 ng/mL. Following initial presentation to gastroenterology at an outside institution, colonoscopy identified mass effect in the rectum suggestive of a protruding external object. A computed tomography (CT) scan of the abdomen and pelvis was then obtained and revealed a mass on the right seminal vesicle. Transrectal ultrasound guided prostate biopsy yielded benign tissue, while final review of the lesion at the authors’ institution returned a diagnosis of schwannoma. To aid in operative planning, magnetic resonance imaging () of the prostate and pelvis was obtained, with and without contrast. This defined a 5.3×4.3×4.3 cm3 mass arising from or abutting the right seminal vesicle, without evidence of invasion into other adjacent structures.
Figure 1

Sagittal view of right seminal vesicle schwannoma (S) on T-2 weighted magnetic resonance imaging. Pertinent structures include the bladder (B), prostate (P), and rectum (R), as labeled.

Sagittal view of right seminal vesicle schwannoma (S) on T-2 weighted magnetic resonance imaging. Pertinent structures include the bladder (B), prostate (P), and rectum (R), as labeled. The patient was counseled regarding the risks, benefits, and alternatives to surgical resection, including a review of open and minimally invasive approaches. He elected to pursue robotic-assisted laparoscopic excision of the mass. Under general anesthesia, the patient was placed in the dorsal lithotomy position. A supraumbilical incision was made with Veress needle used to establish pneumoperitoneum, and ports were placed in the standard W-configuration with a right lower quadrant assistant port, similar to that used for prostatectomy or cystectomy. An approach similar to cystectomy was utilized and the right ureter was identified at its crossing over the iliac vessels. This was dissected free and suspended with a vessel loop to facilitate touch-free manipulation. It was mobilized distally towards the ureterovesical junction at in which point the large seminal vesicle mass was encountered. The mass was not adherently to any surrounding structures and was carefully dissected free. The right vas deferens was then transected proximal to the seminal vesicle. The seminal vesicle and right vas deferens were then divided at their insertion into the prostate. The mass was removed en-bloc with the segment of adherent right vas deferens through the supra-umbilical incision ().
Figure 2

Resected right seminal vesicle schwannoma with adherent section of right vas deferens (V).

Resected right seminal vesicle schwannoma with adherent section of right vas deferens (V). No drains were placed and the estimated blood loss was 100 mL. The patient did well immediately after surgery and was discharged home on the second post-operative day. Final surgical pathology demonstrated a completely excised schwannoma arising from the soft tissue adjacent to the seminal vesicle. The mass was noted to be adherent to the right seminal vesicle capsule.

Discussion

Schwannomas, also called neurilemmomas, are benign neoplasms of Schwann cells that comprise the myelin sheaths around peripheral nerves. Most schwannomas present between ages 20 to 50 and are sporadic, though 10% may be associated with familial syndromes including Neurofibromatosis type II, Schwannomatosis, or Carney complex (1). Schwannomas most often occur in the head and neck region or in the extremities, with pelvic nerve schwannomas being uncommon (2). To date, only 25 cases of pelvic nerve schwannomas are documented, of which only 6 were related to the seminal vesicle (2,3). Schwannomas, with only exceedingly rare exception, carry no risk of malignant transformation (4). Other urologically-relevant schwannomas have been reported. One case involving the pudendal nerve presented as 10 years of right testicular and penile pain, while the masses have also been observed in bladder, and scrotal tissues (2,5,6). The majority of documented pelvic schwannomas have been treated in an extirpative fashion via open surgery, while some case reports described laparoscopic approaches and fewer have detailed robotic-assisted excision (7).

Conclusions

Pelvic schwannomas are rare, usually benign neoplasms that may produce significant symptoms requiring treatment, and command a high degree of clinical suspicion for diagnosis. Robotic-assisted laparoscopy offers a minimally invasive approach to the excision of pelvic lesions. To the authors’ knowledge, this report is the first documented complete excision of a seminal vesicle schwannoma utilizing a robotic assisted laparoscopic approach.
  7 in total

1.  Malignant transformation in a schwannoma.

Authors:  S J Nayler; G Leiman; T Omar; K Cooper
Journal:  Histopathology       Date:  1996-08       Impact factor: 5.087

Review 2.  Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.

Authors:  Fausto J Rodriguez; Constantine A Stratakis; D Gareth Evans
Journal:  Acta Neuropathol       Date:  2011-12-31       Impact factor: 17.088

3.  Giant ancient schwannoma of the urinary bladder presenting as a pelvic mass.

Authors:  K J Ng; A Sherif; S McClinton; S W Ewen
Journal:  Br J Urol       Date:  1993-10

4.  Pudendal schwannoma: A case report and literature review.

Authors:  Clarisse R Mazzola; Nicholas Power; Mark H Bilsky; Roger Robert; Bertrand Guillonneau
Journal:  Can Urol Assoc J       Date:  2014 Mar-Apr       Impact factor: 1.862

Review 5.  Case report--ancient schwannoma of the scrotum.

Authors:  Peter T Chan; Sankalp Tripathi; Su E Low; Lee Q Robinson
Journal:  BMC Urol       Date:  2007-01-23       Impact factor: 2.264

6.  Robot-assisted excision of a large retroperitoneal schwannoma.

Authors:  Vivek Bindal; Parveen Bhatia; Sudhir Kalhan; Mukund Khetan; Suviraj John; Asfar Ali; Rahul Singh; Alok Rath; Sushant Wadhera; Nikunj Bansal
Journal:  JSLS       Date:  2014 Jan-Mar       Impact factor: 2.172

7.  Seminal vesicle schwannoma presenting with left hydroureteronephrosis.

Authors:  Gopalakrishnan Arun; Shrijeet Chakraborti; Santosh Rai; Gurupur Guni Laxman Prabhu
Journal:  Urol Ann       Date:  2014-10
  7 in total
  4 in total

Review 1.  Robotic Nerve Sheath Tumor Resection With Intraoperative Neuromonitoring: Case Series and Systematic Review.

Authors:  Brian P Curry; Reinier Alvarez; Brigitte C Widemann; Matthew Johnson; Piyush K Agarwal; Tanya Lehky; Vladimir Valera; Prashant Chittiboina
Journal:  Oper Neurosurg (Hagerstown)       Date:  2022-02-01       Impact factor: 2.817

2.  Two cases of pelvic schwannomas simultaneously resected with the prostate by robot-assisted surgery.

Authors:  Toshinori Nishikimi; Yasushi Yoshino; Hiroshi Yamada; Hideki Mizuno; Yushi Yamauchi; Tomoyoshi Ohashi; Shigeki Isiguro; Hiroko Morikami; Kikuo Okamura
Journal:  IJU Case Rep       Date:  2021-06-07

3.  Multiple schwannoma of the seminal vesicle: A case report.

Authors:  Yan Zhang; Jing Zhao; Pan Xu; Qi Qi
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

4.  Case report of seminal vesical schwannoma treated with conservative strategy.

Authors:  Peng Zhang; Ming Yang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.